agilon health, inc. (NYSE:AGL) Receives Average Rating of “Hold” from Brokerages

Shares of agilon health, inc. (NYSE:AGL) have been given an average rating of “Hold” by the twenty-one analysts that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have assigned a buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $7.34.

Several brokerages recently commented on AGL. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 target price on shares of agilon health in a report on Wednesday, August 7th. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday. Deutsche Bank Aktiengesellschaft decreased their target price on agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Barclays dropped their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday. Finally, Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd.

agilon health Stock Performance

Shares of NYSE AGL opened at $2.16 on Tuesday. The business’s 50-day simple moving average is $3.22 and its 200-day simple moving average is $4.95. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. agilon health has a 52 week low of $1.80 and a 52 week high of $13.76. The firm has a market cap of $888.80 million, a price-to-earnings ratio of -2.30 and a beta of 0.60.

agilon health (NYSE:AGL) last announced its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 46.06% and a negative net margin of 6.88%. The company had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same period in the previous year, the company earned ($0.06) EPS. As a group, equities research analysts expect that agilon health will post -0.32 earnings per share for the current fiscal year.

Insider Activity

In other agilon health news, CEO Steven Sell purchased 20,000 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 3.20% of the stock is owned by company insiders.

Institutional Investors Weigh In On agilon health

Large investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after buying an additional 371,537 shares in the last quarter. Capital International Investors boosted its stake in shares of agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after purchasing an additional 9,263,296 shares in the last quarter. AQR Capital Management LLC grew its holdings in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares during the last quarter. Bank of New York Mellon Corp increased its position in shares of agilon health by 18.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock worth $7,252,000 after purchasing an additional 174,883 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC lifted its holdings in agilon health by 65.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock valued at $5,262,000 after purchasing an additional 316,856 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.